Sleep Apnea–Specific Hypoxic Burden and Not the Sleepy Phenotype as a Novel Measure of Cardiovascular and Mortality Risk in a Clinical Cohort

by Azarbarzin, A., Mehra, R.
Published 2022

Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial

by Azarbarzin, A., Lombardi, C., Marconi, M., Meriggi, P., Parati, G., Perger, E., Rosa, D., Sands, S.A, Taranto Montemurro, L., Vicini, S., Wellman, A., Zanotti, L.
Published 2022